Verseon hires Buchanan for financial comms
Pharmaceutical company, Verseon Corporation, has appointed Buchanan as the group’s financial PR and investor relations adviser.
The account will be led by Buchanan partner, Henry Harrison-Topham, and will be supported by Mark Court, also a partner, account director Sophie Cowles and account manager Stephanie Watson.
Harrison-Topham, said: “The Buchanan team is really pleased to have been appointed by Verseon. With such a compelling story, Verseon is at the forefront of modern drug discovery and is well placed to potentially change the drug discovery landscape. We look forward to assisting the management team in enhancing their message to their current and future investment audiences.”
Verseon employs a computational drug discovery platform to develop therapeutics for challenging diseases.